Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $252 | $284 | $281 | $194 |
| - Cash | $13 | $7 | $13 | $8 |
| + Debt | $38 | $36 | $32 | $35 |
| Enterprise Value | $277 | $314 | $300 | $220 |
| Revenue | $64 | $60 | $59 | $49 |
| % Growth | 6.7% | 1.4% | 21.7% | – |
| Gross Profit | $49 | $44 | $42 | $35 |
| % Margin | 76.3% | 73.2% | 70.6% | 72% |
| EBITDA | $26 | $7 | $21 | $18 |
| % Margin | 40.1% | 11.5% | 36% | 36.8% |
| Net Income | $17 | $0 | $15 | $13 |
| % Margin | 26.7% | 0.6% | 24.5% | 26.8% |
| EPS Diluted | 6.74 | 0.14 | 5.71 | 5.14 |
| % Growth | 4,714.3% | -97.5% | 11.1% | – |
| Operating Cash Flow | $21 | $13 | $19 | $14 |
| Capital Expenditures | -$3 | -$4 | -$4 | -$4 |
| Free Cash Flow | $18 | $9 | $15 | $10 |